Charles River Laboratories EBITDA 2010-2024 | CRL

Charles River Laboratories EBITDA for the quarter ending September 30, 2024 was $0.206B, a 10.75% decline year-over-year.

  • Charles River Laboratories 2023 EBITDA was 0.931B, a 2.46% decline from 2022.
  • Charles River Laboratories 2022 EBITDA was 0.955B, a 11.63% increase from 2021.
  • Charles River Laboratories 2021 EBITDA was 0.855B, a 28.12% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Charles River Laboratories EBITDA 2010-2024 | CRL

  • Charles River Laboratories 2023 EBITDA was 0.931B, a 2.46% decline from 2022.
  • Charles River Laboratories 2022 EBITDA was 0.955B, a 11.63% increase from 2021.
  • Charles River Laboratories 2021 EBITDA was 0.855B, a 28.12% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.